P
WST icon

&Partners’s West Pharmaceutical WST Stock Holding History

&Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.84M Buy
27,370
+4,317
+19% +$1.32M 0.04% 386
2026
Q1 		$5.79M Buy
23,053
+2,607
+13% +$649K 0.03% 481
2025
Q4 		$5.63M Buy
20,446
+14,753
+259% +$4.04M 0.03% 462
2025
Q3 		$4.56M Buy
5,693
+190
+3% +$46.2K 0.03% 455
2025
Q2 		$1.2M Buy
5,503
+1,256
+30% +$268K 0.01% 888
2025
Q1 		$943K Buy
4,247
+1,311
+45% +$361K 0.01% 857
2024
Q4 		$985K Buy
2,936
+268
+10% +$84.3K 0.01% 773
2024
Q3 		$801K Buy
2,668
+682
+34% +$209K 0.02% 657
2024
Q2 		$654K Buy
+1,986
New +$702K 0.03% 458

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

&Partners's WST Position: Q2 2026 in Review

&Partners increased its West Pharmaceutical (WST) stake by 19% in Q2 2026, buying an estimated $1.32M and bringing the position to 27,370 shares worth $9.84M. The position accounts for 0.04% of the portfolio, ranked #386.

&Partners first reported a position in WST in Q2 2024 and has held it in 9 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • &Partners held 27,370 shares of West Pharmaceutical worth $9.84M as of Q2 2026.
  • &Partners bought 4,317 West Pharmaceutical shares in Q2 2026, an estimated $1.32M.
  • West Pharmaceutical made up 0.04% of &Partners's portfolio in Q2 2026, its #386 holding.
  • &Partners first reported a position in West Pharmaceutical in Q2 2024 and has held it in 9 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.